Scoggin Management’s Bausch Health BHC Stock Holding History

Scoggin Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200,000	Closed	-$3.66M	–	36
2020 Q2	$3.66M	Buy	+200,000	New	+$3.52M	0.98%	15
2016 Q1	–	Sell	-2,500	Closed	-$254K	–	56
2015 Q4	$254K	Buy	+2,500	New	+$281K	0.04%	54
2014 Q4	–	Sell	-5,000	Closed	-$656K	–	85
2014 Q3	$656K	Buy	+5,000	New	+$596K	0.03%	77

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Scoggin Management's BHC Position: Q3 2020 in Review

Scoggin Management sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 200,000 shares — an estimated $3.66M sold.

Scoggin Management first reported a position in BHC in Q3 2014 and held it in 3 quarters. The position peaked at $3.66M in Q2 2020. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Scoggin Management reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Scoggin Management sold 200,000 Bausch Health shares in Q3 2020, an estimated $3.66M.
Scoggin Management first reported a position in Bausch Health in Q3 2014 and held it in 3 quarters.
Scoggin Management's Bausch Health position peaked at $3.66M in Q2 2020.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Scoggin Management's 13F filing for Q3 2020, filed 13 Nov 2020.